@megidigo under this expanded Right to Try they do not have to complete phase 3 clinical trial which would be extremely expensive and they will not have to do this to make their treatment available. This is the only treatment that has actually shown to regenerate nerves and was based on EMG and nerve biopsy. In the patent application they listed successful treatment in cases of neuropathy from chemo treatment and diabetes as well as idiopathic neuropathy. I for one am willing to travel to Montana if this will heal my nerves in my feet and eliminate the neuropathy. Previously they were only approved for Compassionate Early Access by FDA and this was limited only to people with debilitating PN from diabetes.